GPT and Disorder of lipid metabolism: The administration of NaNO3 significantly decreased body weight (Fig. 1m), reduced plasma ALT levels (Fig. 1n), and decreased the NAS score and liver fat accumulation (Fig. 1o, p) in mice with CDHFD-induced lipid metabolic disorder.